Ed Haug

Practice Area: Intellectual Property

Company: Frommer Lawrence & Haug LLP

Ed Haug is a founding partner of Frommer Lawrence & Haug LLP and has served as the firm’s Managing Partner since 2005.

Mr. Haug has been engaged in litigation and counseling involving diverse aspects of intellectual property and competition law for many of the world’s leading companies. He litigates in complex technical fields, including pharmaceuticals and biotechnology, semiconductors and associated manufacturing equipment, e-commerce, automotive designs, GPS technology, and consumer electronics. He also counsels clients regularly in due diligence investigations.

Mr. Haug is nationally recognized as a trial lawyer and consultant specializing in pharmaceutical and biotechnology patent litigation. He has represented clients involved in patent enforcement as well as regulatory and patent challenges involving many of the world’s largest selling pharmaceuticals including Zantac, Paxil, Prozac, Omeprazole, Megace, Adderall XR, Vyvanse, Neurontin, EPO, Trovax, Oxytrol, Carbatrol, and Duoneb.

Mr. Haug has substantial experience in bench, jury trials and appellate practice and has also appeared before the U.K. High Court, German Federal Supreme Court and Tokyo High Court. Mr. Haug has been a regular faculty member of the Practising Law Institute teaching all aspects of trial advocacy in patent cases.

Mr. Haug recently was appointed as an officer of the Federal Circuit Bar Association and is a regular speaker and moderator at its annual conferences around the world. He has been listed in the New York Super Lawyers Metro Edition since 2008 and has also achieved the prestigious AV Preeminent® rating from Martindale-Hubbell®- a peer recognition that places him at the highest level of professional excellence.

Region: New York

Phone: (212) 588-0800

Company: Frommer Lawrence & Haug LLP